LGC launches SARS-CoV-2 Delta Variant quality solution

News (ZH) - Safe, non-infectious, and replication deficient quality solution for Delta variant detection and analysis

Measurement science improves standardisation of SARS-CoV-2 quantification

News (ZH) - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News (ZH) - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News (ZH) - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing